$AVXL News Article - Anavex Life Sciences Announces ANAVEX 2-73 (Blarcamesine) Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://marketwirenews.com/news-releases/anav...36866.html